Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation for its Optical Coherence Tomography Imaging System with ImgAssist AI
Medical Device Investing New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic
Medical Device Investing Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
Pharmaceutical Investing Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19
Psychedelics Investing New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
Psychedelics Investing INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Champignon Brands Inc. on Behalf of Investors
Psychedelics Investing Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Champignon Brands Inc. on Behalf of Investors
Bristol Myers Squibb Receives European Commission Approval for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Psychedelics Investing CHAMPIGNON BRANDS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against Champignon Brands Inc.
Psychedelics Investing SHRMF Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Champignon Brands Inc. Investors of Class Action and Encourages Investors to Contact the Firm